Results 241 to 250 of about 484,668 (274)

Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus. [PDF]

open access: yesSci Rep
Eloranta ML   +9 more
europepmc   +1 more source

Piezo1 specific deletion in endothelial cell protects the progression of pulmonary fibrosis in mice. [PDF]

open access: yesCell Commun Signal
He B   +12 more
europepmc   +1 more source

Declined RTN3 stabilizes DHCR7 to induce cholesterol-dependent tumor progression and MEK inhibitors insensitivity in thyroid cancer. [PDF]

open access: yesCell Death Dis
Ren A   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

HLA-DR meets ERK

Blood, 2010
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire   +2 more sources

ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy

Clinical Cancer Research, 2018
Abstract Purpose: MAPK pathway inhibitors targeting BRAF and MEK have shown clinical efficacy in patients with RAF- and/or RAS-mutated tumors. However, acquired resistance to these agents has been an impediment to improved long-term survival in the clinic.
Bijay S, Jaiswal   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy